These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29856697)

  • 1. Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al.
    Tran PT; Hayman J; Phillips RM
    J Clin Oncol; 2018 Aug; 36(22):2352-2353. PubMed ID: 29856697
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al.
    Ost P; Reynders D; Decaestecker K; Fonteyne V; Lumen N; Lambert B; Delrue L; De Meerleer G
    J Clin Oncol; 2018 Aug; 36(22):2351-2352. PubMed ID: 29856691
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to J. Beyer, T. Tandstad et al, S. Gillessen et al, J. Oldenburg et al, and L.C. Pagliaro et al.
    Vaughn DJ
    J Clin Oncol; 2015 Jul; 33(20):2324-5. PubMed ID: 26033814
    [No Abstract]   [Full Text] [Related]  

  • 4. In reply to Berlin et al.
    Freedland SJ; Stone S
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):240-1. PubMed ID: 24331674
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to R.L. Nussbaum et al and J.S. Dolinsky et al.
    Balmaña J; Nathanson K; Offit K; Robson M; Domchek S
    J Clin Oncol; 2017 Apr; 35(11):1262-1263. PubMed ID: 28135137
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Michael Froehner, Manfred P. Wirth's letter to the editor re: Jim C. Hu, Giorgio Gandaglia, Pierre I. Karakiewicz, et al. Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. Eur Urol 2014;66:666-72.
    Hu JC
    Eur Urol; 2014 Nov; 66(5):e86. PubMed ID: 24882671
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to R.D. Nipp et al, M.-J. Molina-Garrido et al, and A. Gajra et al.
    Corre R; Léna H; Vergnenègre A; Chouaïd C
    J Clin Oncol; 2016 Nov; 34(33):4050-4051. PubMed ID: 27551125
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraoperative radiation therapy after radical prostatectomy: in regard to Saracino et Al. (Int j radiat oncol biol phys, in press).
    Jereczek-Fossa BA; Orecchia R
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):305-6; author reply 306. PubMed ID: 18722291
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to K. Quan et Al, S.P. Collins et al, C.R. King et al, s. Arcangeli et al, d.B. Fuller, and D. Vordermark.
    D'Amico AV
    J Clin Oncol; 2014 Oct; 32(30):3457. PubMed ID: 25185103
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiation dose is predictive of biochemical failure, local failure, and distant metastases. In regard to Kupelian et Al. (Int J Radiat Oncol Biol Phys 2008;71:16-22).
    Kelly P
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1621-2; author reply 1622. PubMed ID: 19028291
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary on dose escalation and biochemical failure in prostate cancer: in regard to Eade et al. (Int. J. Radiat. Oncol. Biol. Phys. 2007;68:682-689).
    Schulz RJ; Kagan AR
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):645; author reply 645-6. PubMed ID: 18207038
    [No Abstract]   [Full Text] [Related]  

  • 12. Comment on dose escalation and biochemical failure in prostate cancer: in regard to Kuban et al. (Int J Radiat Oncol Biol Phys 2008;70:67-74).
    Schulz RJ; Kagan AR
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1288; author reply 1288-9. PubMed ID: 18572089
    [No Abstract]   [Full Text] [Related]  

  • 13. The eternal enigma in prostatic biopsy access route.
    Fabiani A; Principi E; Filosa A; Servi L
    Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to I.F. Tannock, P. Isaacsson Velho et al, R.Z. Szmulewitz et al, M. Tiako Meyo et al, and F.J.S.H. Woei-A-Jin et al.
    Kolesar JM; Liu G
    J Clin Oncol; 2018 Oct; 36(30):3065-3066. PubMed ID: 30188791
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Yuri Tolkach, Markus Kuczyk, Florian Imkamp's letter to the editor re: Eric A. Klein, Matthew R. Cooperberg, Cristina Magi-Galluzzi, et al. A 17-gene assay to predict prostate cancer aggressiveness in the context of gleason grade heterogeneity, tumor multifocality, and biopsy undersampling. Eur urol 2014;66:550-60.
    Klein EA; Cooperberg MR; Carroll PR
    Eur Urol; 2014 Dec; 66(6):e117-8. PubMed ID: 25150174
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to J.B. Aragon-Ching and D. Dalela et al.
    Rusthoven CG; Jones BL; Kavanagh BD; Pugh TJ
    J Clin Oncol; 2017 Mar; 35(8):916-917. PubMed ID: 27937090
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to M.J. Brenner et al and I.R. Vogelius et al.
    Pollack A; Walker G; Horwitz EM; Price R; Feigenberg S; Konski AA; Stoyanova R; Movsas B; Greenberg RE; Uzzo RG; Ma C; Buyyounouski MK
    J Clin Oncol; 2014 Jun; 32(17):1853-4. PubMed ID: 24778402
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to V. Pitini et al and L.J. Costa.
    Thompson CA; Ghesquieres H; Maurer MJ; Cerhan JR; Link BK
    J Clin Oncol; 2015 May; 33(14):1625-6. PubMed ID: 25800767
    [No Abstract]   [Full Text] [Related]  

  • 19. Reply to J.B. Aragon-Ching and D. Dalela et al.
    Aparicio A; Logothetis CJ
    J Clin Oncol; 2017 Mar; 35(8):917-918. PubMed ID: 27937088
    [No Abstract]   [Full Text] [Related]  

  • 20. PSA failure and the risk of death in prostate cancer patients treated with radiotherapy: in regard to Kwan et al. (Int J Radiat Oncol Biol Phys 2004;60:1040-1046).
    Williams S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1253-4; author reply 1254. PubMed ID: 15990030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.